Seeing Is Believing
Healthcare - Sector
with an average price target of $17. This is a potential upside of $245.13 (271.18%) from yesterday's end of day stock price of $4.58.
Verrica Pharmaceuticals's activity chart (see below) currently has 16 price targets and 17 ratings on display.
Analysts average stock forecasts to be materialized ratio is 29.76% with an average time for these price targets to be met of 163.36 days.
Highest price target for VRCA is $17, Lowest price target is $17, average price target is $17.
Most recent stock forecast was given by KEMP DOLLIVER from BROOKLINE on 18-Dec-2025. First documented stock forecast 10-Jul-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 18-Dec-2025
$17
$12.62 (288.13%)
8 months 28 days ago
(18-Dec-2025)
0/2 (0%)
$8.89 (109.62%)
Buy Since 21-Oct-2024
$20
$13.16 (192.40%)
$10
1 years 1 months 2 days ago
(13-Aug-2025)
1/2 (50%)
$13.41 (203.49%)
15
Hold Since 05-Nov-2024
1 years 4 months 1 days ago
(14-May-2025)
3/3 (100%)
$-66.3 (-78.65%)
657
Hold Since 08-Apr-2025
1 years 5 months 7 days ago
(08-Apr-2025)
2/6 (33.33%)
$-80.9 (-85.25%)
602
Buy Since 22-Mar-2023
$3
$-3.84 (-56.14%)
$12
1 years 8 months 9 days ago
(06-Jan-2025)
1/3 (33.33%)
$-3.74 (-55.49%)
141
What is VRCA (Verrica Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on VRCA (Verrica Pharmaceuticals)?
Which analyst has the most public recommendations on VRCA (Verrica Pharmaceuticals)?
Which analyst is the currently most bullish on VRCA (Verrica Pharmaceuticals)?
Which analyst is the currently most reserved on VRCA (Verrica Pharmaceuticals)?